Standard Chemical & Pharmaceutical Co Ltd (1720) — Capital Reinvestment Ratio
Standard Chemical & Pharmaceutical Co Ltd (1720) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$510.55 Million) in capital expenditures (NT$78.71 Million). See 1720 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Standard Chemical & Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2024)
This chart tracks Standard Chemical & Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check total reinvestment intensity of Standard Chemical & Pharmaceutical Co Lt to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
Year-by-year Capital Reinvestment Ratio for Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. For live market cap and broader valuation context, see Standard Chemical & Pharmaceutical Co Lt (1720) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | NT$1.69 Billion | NT$599.61 Million | ▼ -24.4% |
| 2023 | 0.47x | NT$1.34 Billion | NT$625.70 Million | ▼ -52.0% |
| 2022 | 0.98x | NT$1.23 Billion | NT$1.20 Billion | ▲ +270.2% |
| 2021 | 0.26x | NT$827.03 Million | NT$217.92 Million | ▼ -31.0% |
| 2020 | 0.38x | NT$922.58 Million | NT$352.49 Million | ▲ +36.1% |
| 2019 | 0.28x | NT$637.94 Million | NT$179.11 Million | ▼ -19.6% |
| 2018 | 0.35x | NT$484.94 Million | NT$169.36 Million | ▼ -35.8% |
| 2017 | 0.54x | NT$708.74 Million | NT$385.64 Million | ▼ -6.6% |
| 2016 | 0.58x | NT$305.38 Million | NT$177.92 Million | ▲ +111.9% |
| 2015 | 0.27x | NT$650.87 Million | NT$178.98 Million | ▼ -9.8% |
| 2014 | 0.30x | NT$582.30 Million | NT$177.53 Million | ▼ -69.2% |
| 2013 | 0.99x | NT$427.26 Million | NT$422.73 Million | ▲ +61.3% |
| 2012 | 0.61x | NT$402.25 Million | NT$246.76 Million | ▼ -16.7% |
| 2011 | 0.74x | NT$405.49 Million | NT$298.50 Million | ▼ -35.2% |
| 2010 | 1.14x | NT$272.47 Million | NT$309.66 Million | ▲ +170.8% |
| 2009 | 0.42x | NT$634.23 Million | NT$266.14 Million | ▲ +56.8% |
| 2008 | 0.27x | NT$719.17 Million | NT$192.50 Million | ▲ +19.1% |
| 2007 | 0.22x | NT$323.60 Million | NT$72.72 Million | ▼ -15.1% |
| 2006 | 0.26x | NT$358.75 Million | NT$95.01 Million | ▲ +93.4% |
| 2005 | 0.14x | NT$370.77 Million | NT$50.78 Million | ▲ +12.2% |
| 2004 | 0.12x | NT$335.45 Million | NT$40.95 Million | ▼ -77.8% |
| 2003 | 0.55x | NT$272.89 Million | NT$149.81 Million | ▼ -57.9% |
| 2002 | 1.30x | NT$147.75 Million | NT$192.54 Million | — |